| Financial Year |
March 31 2023 |
| Monetary Funds |
835,377,050.91 |
| Held-for-trading Financial Assets |
1,405,000,000.00 |
| Notes Receivable |
23,500,000.00 |
| Accounts Receivable |
810,444,191.16 |
| Advances to Suppliers |
316,867,056.74 |
| Other Receivables |
44,679,943.47 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
87,674,877.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
61,050,644.40 |
| Total Current Assets |
3,584,593,764.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,421,755.14 |
| Investment Properties |
-- |
| Fixed Assetes |
4,578,410.57 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
921,815,341.75 |
| R&D expenses |
-- |
| Goodwill |
434,254,992.04 |
| Long-Term Deferred and Prepaid Expenses |
2,990,539.70 |
| Deferred Income Tax Assets |
45,458,486.22 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,474,988,297.72 |
| Total Assets |
5,059,582,062.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
39,326,085.96 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
6,056,812.92 |
| Taxes Payable |
28,707,684.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
271,034,494.51 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,014,985.65 |
| Other Current Liabilities |
21,464,845.80 |
| Sub-Total of Current Liabilities |
593,480,763.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
12,750,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
36,751,129.82 |
| Total Liabilities |
630,231,893.62 |
| Paid-In Capital(Or Share Stock) |
417,326,994.00 |
| Capital Surplus |
1,499,444,716.37 |
| Surplus Reserve |
241,865,509.10 |
| LESS:Treasury Stock |
1,122,606,872.60 |
| Undistributed Profits |
3,393,529,013.00 |
| Minority Stockholder's Interest |
-209,191.45 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,429,559,359.87 |
| Owner's Equity（Stockholder's Equity） |
4,429,350,168.42 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,059,582,062.04 |
